 Healio | R-BAC shows promise in mantle cell lymphoma Healio Combination therapy with cytarabine, bendamustine and rituximab was associated with strong response-related outcomes in mantle cell lymphoma, according to results of a phase 2 study. The researchers investigated the R-BAC combination — cytarabine, ... |
